Drug class

Nitrogen Mustard Derivatives

Nitrogen mustard derivatives are a foundational class of cytotoxic alkylating antineoplastic agents structurally derived from bis-(2-chloroethyl)amines. Read more about Nitrogen Mustard Derivatives

62 drugs in this class 45 manufacturers

Advertisement

Drugs in Nitrogen Mustard Derivatives

Showing 1–9 of 62 drugs

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES · RETINOBLASTOMA ·+17
Baxter Healthcare Company

IFEX (ifosfamide)

NITROGEN MUSTARD DERIVATIVES · TESTICULAR GERM CELL TUMOR
Baxter Healthcare Company

MELPHALAN HCL

NITROGEN MUSTARD DERIVATIVES · MULTIPLE MYELOMA
MYLAN INSTITUTI

IFOSFAMIDE

NITROGEN MUSTARD DERIVATIVES · TESTICULAR GERM CELL TUMOR
Baxter Healthcare Company

IFEX (ifosfamide)

NITROGEN MUSTARD DERIVATIVES · TESTICULAR GERM CELL TUMOR
Baxter Healthcare Company

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES · RETINOBLASTOMA ·+17
Baxter Healthcare Company
Filter & compare in the drug finder → Opens the drug finder with Nitrogen Mustard Derivatives preselected. Add indication or manufacturer filters there.

About Nitrogen Mustard Derivatives.

Nitrogen mustard derivatives are a foundational class of cytotoxic alkylating antineoplastic agents structurally derived from bis-(2-chloroethyl)amines.

They exert their principal therapeutic effect by forming reactive aziridinium intermediates that covalently bind to DNA bases—chiefly guanine residues—producing intra- and inter-strand cross-links that disrupt replication and transcription, ultimately triggering apoptotic cell death in rapidly dividing cells.

Clinically represented by agents such as cyclophosphamide, chlorambucil, melphalan, ifosfamide, and bendamustine, this class is widely employed in oncology and hematology to treat leukemias, lymphomas, multiple myeloma, and various solid tumors, as well as serving key immunosuppressive roles in conditioning regimens for stem cell transplantation and severe autoimmune disorders.